Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
LEVOleucovorin
LEVOleucovorin
- Restricted Khapzory --> Restricted to shortage of leucovorin injection.
- Restricted Miscellaneous Program Formulary
- Therapeutic Interchange
VIEW MORE Antidotes
Last updated: Mar. 6, 2019
LEVOleucovorin calcium (Fusilev) and LEVOleucovorin sodium (Khapzory) is to be interchanged to leucovorin. LEVOleucovorin is dosed at 1/2 the prescribded leucovorin dose.
Khapzory (LEVOleucovorin sodium) is formulary restricted for use when leucovorin injection is unavailable or patient is utilizing Khapzory patient assistance program.
Fusilev (LEVOleucovorin calcium) has been discontinuted by the manufacturer. Khapzory (LEVOleucovorin sodium) is therapeutically interchangeable with Fusilev (1:1 conversion).
Reviewed: October 28, 2008, and November 16, 2010, and 26 Feb 2019 (Khapzory)